All Industries

Top Biotech Companies

7,741 Biotech companies, sorted by total funding raised.

Guardant HealthIPO

Guardant Health develops blood tests and data-driven precision-oncology solutions that help clini...

Palo Alto, United States1001–5000Biotech, Healthcare
Series ETotal funding$550.0MMay 2017
Arcus BiosciencesIPO

Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...

Hayward, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$544.0MJan 2024
GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord))Acquired

Genomics and data analytics company providing drug discovery and development services to global b...

Cambridge, United StatesBiotech, Healthcare
Series CTotal funding$530.0MNov 2018
Beam TherapeuticsIPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United States201–500Biotech, Healthcare
Growth EquityTotal funding$528.0MFeb 2026
ApellisAcquired

Global biopharmaceutical company developing targeted C3 therapies to treat diseases driven by exc...

Waltham, United States501–1000Biotech, Healthcare
Corporate RoundTotal funding$522.6MFeb 2023
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series CTotal funding$520.0MDec 2018
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United States51–200Biotech, Therapeutics
Series FTotal funding$514.0MSep 2026
Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing innovative therap...

Westlake Village, United States51–200Biotech, Healthcare
Series DTotal funding$506.0MFeb 2026
MetseraAcquired

Clinical-stage biopharmaceutical company developing next-generation oral and injectable medicines...

New York, United States11–50Biotech
Series BTotal funding$505.0MNov 2024
ADC Therapeutics SA Common SharesIPO

Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.

Lausanne, Switzerland201–500Biotech, Healthcare
Series ETotal funding$501.0MJun 2019
Summit Therapeutics Inc.IPO

Summit Therapeutics develops oncology therapies intended to improve quality and potential duratio...

Miami, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$500.0MOct 2025
RecursionIPO

AI-powered drug discovery and development company that uses biological and chemical datasets, mac...

Salt Lake City, United States501–1000Artificial Intelligence, Biotech
Corporate RoundTotal funding$497.9MJul 2023
Carmot TherapeuticsAcquired

Carmot Therapeutics was a clinical-stage biotech developing GLP-1-based therapeutics for obesity ...

Berkeley, United States11–50Biotech, Therapeutics
Series ETotal funding$497.0MMay 2023
RAPT TherapeuticsIPO

Clinical-stage biopharmaceutical developing immune-targeting therapeutics for inflammatory and im...

San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$497.0MOct 2025
Biohaven Ltd. Common SharesIPO

Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...

New Haven, United States201–500Biotech, Healthcare
Venture RoundTotal funding$493.6MAug 2020
GenentechIPO

Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

San Francisco, United States10001+Biotech, Drug Discovery
Corporate RoundTotal funding$492.3MFeb 1990
LarondeClosed

Endless RNA therapeutics for durable protein expression

Cambridge, United States11–50Biotech, Healthcare
Series BTotal funding$490.0MAug 2021
Piramal Pharma

India-based pharmaceutical company offering CDMO services, critical care products, and consumer h...

Mumbai, India10001+Biotech, Healthcare
Corporate RoundTotal funding$490.0MJun 2020
Kallyope

Kallyope leverages unique insights into neural signaling pathways to develop innovative medicines...

New York, United States51–200Biotech, Drug Discovery
GrantTotal funding$487.2MMay 2023
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series DTotal funding$473.3MAug 2026
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Venture RoundTotal funding$470.0MDec 2024
SynthegoAcquired

Synthego provides CRISPR solutions, reagents, and expertise that help researchers and therapeutic...

Redwood City, United States51–200Biotech, Genomics
Series ETotal funding$468.6MFeb 2022
Pathos

Pathos uses multimodal oncology data and AI to simulate clinical trials, identify responsive pati...

Chicago, United States51–200Artificial Intelligence, Biotech
Series DTotal funding$467.0MMay 2025
DNA Script

DNA Script develops the SYNTAX platform for enzymatic DNA synthesis, enabling labs to print high-...

Paris, France51–200Biotech, Synthetic Biology
Series CTotal funding$466.5MJan 2022
InvivydIPO

Invivyd develops antibody-based medicines using an integrated technology platform to protect vuln...

Waltham, United States51–200Biotech, Healthcare
Series CTotal funding$466.0MApr 2021